This site is intended for healthcare professionals only
LoginRegister
Akums Secures First UK MHRA Approval for RivaroxabanCDSCO panel rejects Akums Drugs Proposal for PK/PD study of Cholecalciferol aqueous injection
Mankind Pharma Gets Relief as CGST Appellate Authority Drops Rs 1.02 Cr PenaltyRevise Phase III protocol: CDSCO Panel Tells Mankind Over Roflumilast Cream
Merck KGaA in late-stage talks to acquire SpringWorks for USD 3.5 billionMerck KGaA in late-stage talks to acquire SpringWorks for USD 3.5 billion
USV Acquires 79% Stake in Wellbeing Nutrition, Values D2C Startup at Rs 1,583 CrZydus Lifesciences inks pact with PAI Partners, other shareholders to buy majority stake in...
CDSCO Expert Panel Backs Akums Faropenem Dispersible Tablets, Grants CT, BE WaiversAkums Drugs, Tamil Nadu Agricultural University collaborate for pharmaceutical innovation
Abuse of the Process of Law: Delhi HC Upholds Dismissal of Complaint Against Hospital, Doctor Accused of Medical NegligenceCough Syrup Warning Will Not Affect Existing Stock: HC Relief to Glenmark, Zuventus
Torrent Pharma Appoints Former Cipla Global CTO Geena Malhotra as Chief Technology OfficerTorrent Pharmaceutical Gets CDSCO Panel Nod To study Semaglutide Tablets
Bristol Myers Squibb, Bain Capital form new biopharmaceutical company - NewCoMerger of Suven Pharma, Cohance Lifesciences to take effect from May 1
Biocon Secures USFDA Nod for Generic Liraglutide Prefilled Pens for DiabetesBiocon Biologics receives EMA Committee positive opinions for Biosimilar Denosumab for bone health
Himachal cracks down on pharma units, action taken against four facilitiesZydus Gujarat unit gets 6 USFDA observations
Aurobindo Pharma Slapped Rs 170 Crore GST DemandAurobindo Pharma arm CuraTeQ Biologics gets positive opinion for breast cancer drug Dazublys from...
Azithromycin, Ofloxacin Combos Among 3 Drug Batches Flagged as Purportedly Spurious by CDSCOBatch of Telma AM earlier classified as NSQ now flagged as Spurious
X